BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2550747)

  • 1. Regulation of thymidine kinase activity in mouse L cells biochemically transformed by varicella-zoster virus.
    Shiraki K; Mori H; Hayakawa Y; Yamanishi K; Takahashi M
    Microbiol Immunol; 1989; 33(8):693-8. PubMed ID: 2550747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical transformation of mouse cells by varicella-zoster virus.
    Yamanishi K; Matsunaga Y; Ogino T; Lopetegui P
    J Gen Virol; 1981 Oct; 56(Pt 2):421-30. PubMed ID: 6273503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript.
    Sawyer MH; Ostrove JM; Felser JM; Straus SE
    Virology; 1986 Feb; 149(1):1-9. PubMed ID: 3004022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET.
    Deroose CM; Chitneni SK; Gijsbers R; Vermaelen P; Ibrahimi A; Balzarini J; Baekelandt V; Verbruggen A; Nuyts J; Debyser Z; Bormans GM; Mortelmans L
    Nucl Med Biol; 2012 Nov; 39(8):1266-74. PubMed ID: 22981986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the non-sense mutants of varicella-zoster virus thymidine kinase.
    Suzutani T; Koyano S; Saijo M; Chiba A; Azuma M
    Arch Virol; 1997; 142(10):2059-64. PubMed ID: 9413514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of varicella-zoster virus-related antigens in biochemically transformed cells.
    Lopetegui P; Matsunaga Y; Okuno T; Ogino T; Yamanishi K
    J Gen Virol; 1983 May; 64(Pt 5):1181-6. PubMed ID: 6302213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase.
    Mahalingam R; Cabirac G; Wellish M; Gilden D; Vafai A
    Virus Genes; 1990 Jul; 4(2):105-20. PubMed ID: 1698324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
    Suzutani T; Davies LC; Honess RW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades.
    Hoffmann A; Döring K; Seeger NT; Bühler M; Schacke M; Krumbholz A; Sauerbrei A
    J Clin Virol; 2017 Oct; 95():61-65. PubMed ID: 28886462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxythymidine kinases in varicella-zoster virus infected and biochemically transformed cells.
    Ogino T; Lopetegui P; Yamanishi K
    Biken J; 1982 Sep; 25(3):149-56. PubMed ID: 6299267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.
    Chiba A; Suzutani T; Saijo M; Koyano S; Azuma M
    Acta Virol; 1998 Dec; 42(6):401-7. PubMed ID: 10358747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus.
    Suzutani T; Lacey SF; Powell KL; Purifoy DJ; Honess RW
    J Virol; 1992 Apr; 66(4):2118-24. PubMed ID: 1312622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the thymidine kinase gene of thymidine kinase-deficient mutants of varicella-zoster virus.
    Mori H; Shiraki K; Kato T; Hayakawa Y; Yamanishi K; Takahashi M
    Intervirology; 1988; 29(6):301-10. PubMed ID: 2852653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-mediated transfer of herpes simplex virus TK gene to human TK- cells: properties of the transformed lines.
    Bacchetti S; Graham FL
    IARC Sci Publ (1971); 1978; (24 Pt 1):495-9. PubMed ID: 221353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modelling and docking studies on Varicella Zoster Virus Thymidine kinase.
    Spadola L; Novellino E; Folkers G; Scapozza L
    Eur J Med Chem; 2003 Apr; 38(4):413-9. PubMed ID: 12750029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame.
    Sahli R; Andrei G; Estrade C; Snoeck R; Meylan PR
    Antimicrob Agents Chemother; 2000 Apr; 44(4):873-8. PubMed ID: 10722484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
    Bevilacqua F; Davis-Poynter N; Worrallo J; Gower D; Collins P; Darby G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1927-35. PubMed ID: 7636473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
    Yokota T; Konno K; Shigeta S; De Clercq E
    Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.